Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in acute interstitial nephritis
NCT04376216Phase 4Recruiting
- Sponsor
- Central Denmark Region
- Start
- Sep 2017
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone in Acute tubulointerstitial nephritis (ATIN) (2 arms), sponsored by Central Denmark Region. Primary endpoint: Estimated Glomerular Filtration Rate at 3 months. Started Sep 2017; status: recruiting.
02
Drugs
prednisone
03
Conditions
Acute tubulointerstitial nephritis (ATIN)
Beyond the preview
Go deeper on NCT04376216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04376216.